SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0001213900-22-079844
Filing Date
2022-12-14
Accepted
2022-12-14 17:30:00
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 5247
2 GRAPHIC image_001.jpg GRAPHIC 3907
  Complete submission text file 0001213900-22-079844.txt   11750
Mailing Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000
Business Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)